Research Article

Seroconversion and Prevalence of Hepatitis B Surface Antigen among Vaccinated Health Care Workers in Ashanti Region, Ghana

Table 3

Bivariate and multivariate analyses of some factors associated with seroconversion status among HCWs.

VariableCrude odds ratio95% CIAdjusted odds ratio95% CI

Age, years (N  = 424)
 <20Reference
 20–292.760.64–11.952.860.66–12.43
 30–391.470.33–6.491.490.34–6.58
 ≥400.270.04–1.750.280.04–1.78
Sex
 FemaleReference
 Male1.040.68–1.590.900.58–1.40
Location HBV was administered
 HospitalReference
 School1.260.83–1.920.910.57–1.45
 Other0.890.32–2.691.160.38–4.03
Who administered HBV
 Nurse or doctorReference
 Medical laboratory scientist0.960.60–1.531.090.61–1.95
 Other1.000.31–3.841.170.34–4.71
 Don’t remember0.730.42–1.290.730.42–1.29
Route of administration
 IntramuscularReference
 Subcutaneous0.820.36–1.991.040.36–3.07
 Do not know0.740.40–1.410.640.34–1.31
Number of doses received
 2Reference
 33.731.95–7.343.861.99–7.37
Years since last vaccination
 <1Reference
 1–40.260.10–0.740.240.08–0.61
 5–100.240.09–0.660.240.09–0.66
 >100.150.04–0.700.150.04–0.70
Booster taken
 NoReference
 Yes4.121.41–17.564.091.38–17.57
Had vaccination record card
 YesReference
 No0.520.34–0.790.570.38–0.81

CI, confidence interval; crude odds ratios and adjusted odds ratios significantly higher or lower than 1 are shown in bold.